154 related articles for article (PubMed ID: 2326874)
1. Failure of cell surface expression of a class I major histocompatibility antigen caused by somatic point mutation.
Zeff RA; Nakagawa M; Mashimo H; Gopas J; Nathenson SG
Transplantation; 1990 Apr; 49(4):803-8. PubMed ID: 2326874
[TBL] [Abstract][Full Text] [Related]
2. Analysis of somatic cell H-2 variants to define the structural requirements for class I antigen expression.
Zeff RA; Gopas J; Steinhauer E; Rajan TV; Nathenson SG
J Immunol; 1986 Aug; 137(3):897-903. PubMed ID: 3722821
[TBL] [Abstract][Full Text] [Related]
3. Failure in expression of structurally altered (CYS164-->TYR) H-2Kb molecules is mitigated with high affinity peptide-ligand.
Tatake RJ; Zeff RA
Transplantation; 1995 May; 59(9):1343-9. PubMed ID: 7762072
[TBL] [Abstract][Full Text] [Related]
4. A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations.
Dal Porto J; Johansen TE; Catipović B; Parfiit DJ; Tuveson D; Gether U; Kozlowski S; Fearon DT; Schneck JP
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6671-5. PubMed ID: 8341685
[TBL] [Abstract][Full Text] [Related]
5. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
[TBL] [Abstract][Full Text] [Related]
6. Expression of murine H-2Kb histocompatibility antigen in cells transformed with cloned H-2 genes.
Mellor AL; Golden L; Weiss E; Bullman H; Hurst J; Simpson E; James RF; Townsend AR; Taylor PM; Schmidt W; Ferluga J; Leben L; Santamaria M; Atfield G; Festenstein H; Flavell RA
Nature; 1982 Aug; 298(5874):529-34. PubMed ID: 6285197
[TBL] [Abstract][Full Text] [Related]
7. Somatic cell variants of H-2Kb: a point mutation in the first extracellular domain results in altered immune recognition.
Nakagawa M; Zeff RA; Geier SS; Bluestone JA; Nathenson SG
Immunogenetics; 1986; 24(6):381-5. PubMed ID: 3491786
[TBL] [Abstract][Full Text] [Related]
8. Structural basis of Kbm8 alloreactivity. Amino acid substitutions on the beta-pleated floor of the antigen recognition site.
Hunt HD; Pullen JK; Dick RF; Bluestone JA; Pease LR
J Immunol; 1990 Sep; 145(5):1456-62. PubMed ID: 2384667
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of allorecognition by an H-2Kb-derived peptide is evidence for a T-cell binding region on a major histocompatibility complex molecule.
Schneck J; Munitz T; Coligan JE; Maloy WL; Margulies DH; Singer A
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8516-20. PubMed ID: 2813409
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
11. Expression and T cell recognition of hybrid antigens with amino-terminal domains encoded by Qa-2 region of major histocompatibility complex and carboxyl termini of transplantation antigens.
Stroynowski I; Forman J; Goodenow RS; Schiffer SG; McMillan M; Sharrow SO; Sachs DH; Hood L
J Exp Med; 1985 May; 161(5):935-52. PubMed ID: 2580938
[TBL] [Abstract][Full Text] [Related]
12. Analysis of coreceptor versus accessory molecule function of CD8 as a correlate of exogenous peptide concentration.
Knall C; Ingold A; Potter TA
Mol Immunol; 1994 Aug; 31(12):875-83. PubMed ID: 8065371
[TBL] [Abstract][Full Text] [Related]
13. Cis- and trans-repression of class I major histocompatibility gene expression in Abelson virus-transformed murine leukemia.
Zeff RA; Zhao YF; Tatake R; Lachman H; Borriello F; Nathenson SG
Blood; 1991 Jul; 78(2):524-32. PubMed ID: 2070089
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the promoter regions of H-2Kb and H-2Kbm1 class I MHC genes.
Ozawa K; Saka F; Kitabayashi I; Imai T; Soeda E; Israel A; Gachelin G; Yokoyama K
Nucleic Acids Res; 1990 Jul; 18(14):4185-90. PubMed ID: 2377459
[TBL] [Abstract][Full Text] [Related]
15. The allorecognition of H-2Kb-specific CD4-CD8- T cell hybridomas is influenced by the substitution at residue 256 of MHC class I molecules.
Tanabe M; Minami M; Kano K; Takiguchi M
J Immunol; 1990 Sep; 145(6):1968-73. PubMed ID: 2118159
[TBL] [Abstract][Full Text] [Related]
16. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
Jennings SR
J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
[TBL] [Abstract][Full Text] [Related]
17. H-2Kb antigen expression has no effect on natural killer susceptibility and tumorigenicity of a murine hepatoma.
Nishimura MI; Stroynowski I; Hood L; Ostrand-Rosenberg S
J Immunol; 1988 Dec; 141(12):4403-9. PubMed ID: 3264312
[TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
19. Control of metastatic properties of BL6 melanoma cells by H-2Kb gene: immunological and nonimmunological mechanisms.
Gorelik E; Kim M; Duty L; Henion T; Galili U
Clin Exp Metastasis; 1993 Nov; 11(6):439-52. PubMed ID: 8222393
[TBL] [Abstract][Full Text] [Related]
20. Allospecific cytolytic T lymphocytes recognize conformational determinants on hybrid mouse transplantation antigens.
Bluestone JA; Foo M; Allen H; Segal D; Flavell RA
J Exp Med; 1985 Jul; 162(1):268-81. PubMed ID: 2409207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
